| RS397515284 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS397515285 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autism spectrum disorder, Tuberous sclerosis 2 |
| RS397515287 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Lymphangiomyomatosis |
| RS397515288 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS397515291 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
beta Thalassemia, beta Thalassemia |
| RS397515293 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 1 |
| RS397515294 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 1 |
| RS397515296 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS397515297 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS397515301 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS397515302 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS397515303 |
TSC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS397515305 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis syndrome |
| RS397515306 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS397515309 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS397515310 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS397515315 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS397515316 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS397515318 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS397515319 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS397515320 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS397515321 |
DPAGT1
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 13, DPAGT1-congenital disorder of glycosylation |
| RS397515322 |
DPAGT1
|
Health Risk |
Pathogenic |
DPAGT1-congenital disorder of glycosylation, DPAGT1-congenital disorder of glycosylation |
| RS397515323 |
PDK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease X-linked dominant 6, Charcot-Marie-Tooth disease X-linked dominant 6 |
| RS397515324 |
SF3B4
|
Health Risk |
Pathogenic |
Nager syndrome, Nager syndrome |
| RS397515325 |
ACTA2
|
Health Risk |
Pathogenic |
Aortic aneurysm, familial thoracic 6 |
| RS397515326 |
HNRNPA2B1
|
Health Risk |
Pathogenic |
Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2, Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2 |
| RS397515327 |
DPAGT1
|
Health Risk |
Pathogenic/Likely pathogenic |
DPAGT1-congenital disorder of glycosylation, Congenital disorder of glycosylation |
| RS397515328 |
DPAGT1
|
Health Risk |
Conflicting classifications of pathogenicity |
DPAGT1-congenital disorder of glycosylation, Congenital myasthenic syndrome 13 |
| RS397515329 |
DPAGT1
|
Health Risk |
Pathogenic |
DPAGT1-congenital disorder of glycosylation, DPAGT1-congenital disorder of glycosylation |
| RS397515330 |
PRKG1
|
Health Risk |
Pathogenic |
Aortic aneurysm, familial thoracic 8 |
| RS397515332 |
COL6A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS397515333 |
COL6A2
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS397515334 |
WDR35
|
Health Risk |
Pathogenic |
Cranioectodermal dysplasia 2, Short-rib thoracic dysplasia 7 with or without polydactyly |
| RS397515335 |
SDCCAG8
|
Health Risk |
Pathogenic |
Senior-Loken syndrome 7, Bardet-Biedl syndrome |
| RS397515336 |
SDCCAG8
|
Health Risk |
Pathogenic |
Senior-Loken syndrome 7, Senior-Loken syndrome 7 |
| RS397515337 |
SDCCAG8
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 16, Senior-Loken syndrome 7 |
| RS397515338 |
HPSE2
|
Health Risk |
Pathogenic/Likely pathogenic |
Urofacial syndrome type 1, Urofacial syndrome type 1 |
| RS397515339 |
DNAAF1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 13, Kartagener syndrome |
| RS397515340 |
RSPH9
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia 12, Primary ciliary dyskinesia |
| RS397515341 |
DNAAF2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 10, Kartagener syndrome |
| RS397515342 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form |
| RS397515343 |
GBE1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form |
| RS397515344 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form |
| RS397515345 |
USH1G
|
Health Risk |
Pathogenic |
Usher syndrome type 1G, Usher syndrome type 1 |
| RS397515346 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS397515347 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, HGD-related disorder |
| RS397515349 |
UROS
|
Health Risk |
Pathogenic |
Cutaneous porphyria, Cutaneous porphyria |
| RS397515350 |
UROS
|
Health Risk |
Pathogenic |
Cutaneous porphyria, Cutaneous porphyria |
| RS397515351 |
UROS
|
Health Risk |
Pathogenic |
Cutaneous porphyria, Cutaneous porphyria |
| RS397515352 |
CLN6
|
Health Risk |
Pathogenic |
Ceroid lipofuscinosis, neuronal |
| RS397515353 |
CYP27A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS397515354 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, Cholestanol storage disease |
| RS397515355 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, CYP27A1-related disorder |
| RS397515356 |
CYP27A1
|
Health Risk |
Pathogenic |
Cholestanol storage disease, CYP27A1-related disorder |
| RS397515357 |
STIM1
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to STIM1 deficiency, Combined immunodeficiency due to STIM1 deficiency |
| RS397515358 |
DNAI2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 9, Primary ciliary dyskinesia |
| RS397515359 |
USH1C
|
Health Risk |
Pathogenic |
Usher syndrome type 1C, Usher syndrome type 1 |
| RS397515360 |
CNGB3
|
Health Risk |
Pathogenic/Likely pathogenic |
Achromatopsia 3, Retinal dystrophy |
| RS397515361 |
SP110
|
Health Risk |
Pathogenic |
Hepatic veno-occlusive disease-immunodeficiency syndrome, Hepatic veno-occlusive disease-immunodeficiency syndrome |
| RS397515362 |
SP110
|
Health Risk |
Pathogenic |
Hepatic veno-occlusive disease-immunodeficiency syndrome, Hepatic veno-occlusive disease-immunodeficiency syndrome |
| RS397515363 |
DNAI1
|
Health Risk |
Pathogenic |
Kartagener syndrome, Primary ciliary dyskinesia |
| RS397515364 |
ZIC2
|
Health Risk |
Pathogenic |
Holoprosencephaly 5, Holoprosencephaly 5 |
| RS397515365 |
ZIC2
|
Health Risk |
Pathogenic |
Holoprosencephaly 5, Holoprosencephaly 5 |
| RS397515366 |
SOX10
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 4C, Waardenburg syndrome type 4C |
| RS397515367 |
SOX10
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 4C, Waardenburg syndrome type 4C |
| RS397515368 |
SOX10
|
Health Risk |
Likely pathogenic |
PCWH syndrome, PCWH syndrome |
| RS397515369 |
SOX10
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 2E, without neurologic involvement |
| RS397515370 |
SOX10
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 2E, with neurologic involvement |
| RS397515371 |
SOX10
|
Health Risk |
Conflicting classifications of pathogenicity |
PCWH syndrome, Charcot-Marie-Tooth disease |
| RS397515372 |
SOX10
|
Health Risk |
Pathogenic |
PCWH syndrome, PCWH syndrome |
| RS397515373 |
MSTN
|
Health Risk |
Pathogenic |
Myostatin-related muscle hypertrophy, Myostatin-related muscle hypertrophy |
| RS397515374 |
PTEN
|
Health Risk |
Pathogenic |
Cowden syndrome 1, PTEN hamartoma tumor syndrome |
| RS397515375 |
SHH
|
Health Risk |
Pathogenic |
Holoprosencephaly 3, Holoprosencephaly 3 |
| RS397515376 |
SHH
|
Health Risk |
Pathogenic |
Holoprosencephaly 3, Holoprosencephaly 3 |
| RS397515377 |
TTPA
|
Health Risk |
Pathogenic |
ATAXIA, FRIEDREICH-LIKE |
| RS397515378 |
TTPA
|
Health Risk |
Pathogenic |
ATAXIA, FRIEDREICH-LIKE |
| RS397515379 |
TTPA
|
Health Risk |
Pathogenic |
ATAXIA, FRIEDREICH-LIKE |
| RS397515381 |
SMS
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Snyder type, Syndromic X-linked intellectual disability Snyder type |
| RS397515382 |
ATP1A3
|
Health Risk |
Pathogenic |
Dystonia 12, Dystonia 12 |
| RS397515383 |
NDUFS1
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 5 |
| RS397515384 |
GNAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Achromatopsia 4, Achromatopsia 4 |
| RS397515385 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS397515386 |
SOX10
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 2E, without neurologic involvement |
| RS397515387 |
SOX10
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 2E, without neurologic involvement |
| RS397515388 |
RBM8A
|
Health Risk |
Pathogenic |
Radial aplasia-thrombocytopenia syndrome, Radial aplasia-thrombocytopenia syndrome |
| RS397515389 |
RBM8A
|
Health Risk |
Pathogenic |
Radial aplasia-thrombocytopenia syndrome, Radial aplasia-thrombocytopenia syndrome |
| RS397515390 |
STIM1
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to STIM1 deficiency, Combined immunodeficiency due to STIM1 deficiency |
| RS397515391 |
SLC46A1
|
Health Risk |
Pathogenic |
Congenital defect of folate absorption, Congenital defect of folate absorption |
| RS397515392 |
CCDC39
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 14, Primary ciliary dyskinesia |
| RS397515393 |
CCDC40
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 15, Primary ciliary dyskinesia |
| RS397515395 |
DNAAF3
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 2, Primary ciliary dyskinesia 2 |
| RS397515396 |
CRPPA
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS397515397 |
CRPPA
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS397515398 |
CRPPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS397515399 |
NKX2-5
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial isolated congenital asplenia, Cardiovascular phenotype |
| RS397515401 |
ASXL1
|
Health Risk |
Pathogenic |
Bohring-Opitz syndrome, Bohring-Opitz syndrome |
| RS397515402 |
KCNT1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 14 |
| RS397515403 |
KCNT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 14 |
| RS397515404 |
KCNT1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 14 |